title: [Diffusion and perfusion MR imaging in cerebral lymphomas].
abstract: Because of the increasing incidence of cerebral lymphoma, it is critical for patient management to recognize the MR features of this disease. We present the characteristic morphological and functional MRI features of this tumor. The findings on MRI studies, including morphological, diffusion and perfusion imaging, performed in 9 biopsy-proven cases of cerebral lymphoma with 13 lesions are presented and analyzed, and are discussed in comparison with published literature data. All patients underwent diffusion-weighted imaging with a single shot echo-planar pulse sequence. Dynamic susceptibility-contrast MRI was performed using a T2*-weighted gradient-echo echo-planar sequence after intravenous injection of chelates of gadolinium at the rate of 6 ml/s and a temporal resolution of 1 second. All cases of cerebral lymphoma appeared hypointense or isointense on T1-weighted images and in 75% of cases iso- or hypointense on T2-weighted images. All lesions enhanced except one in a patient receiving steroid therapy. On diffusion-weighted images, tumours were hyperintense with normal or decreased ADC values (0.717+/-0.152.10-3 mm2/sec, range: 0.550-1.014) and an ADC ratio tumour/normal white matter of 0.974+/-0.190 (range: 0.768-1.410). On perfusion, the signal intensity-time curve of each tumour showed a characteristic type of curve with a significant increase of the signal intensity above the baseline and a low maximum relative cerebral blood volume ratio (rCVBmax) of 1.43+/-0.64 (0.55-2.62). Due to their higher cellularity, the lack of neoangiogenesis, and the increased permeability of the blood-brain barrier related to the infiltration of blood vessels wall by lymphomatous cells, cerebral lymphoma presents characteristic diffusion and perfusion MRI features that should be useful for diagnosis and patient follow-up.
authors.affiliation: Service de Radiologie et IRM, Centre Hospitalier Lyon Sud, Hospices civils de Lyon, 69495 Pierre Bénite Cedex. francois.cotton@chu-lyon.fr
authors.forename: F
authors.initials: F
authors.lastname: Cotton
authors.forename: P
authors.initials: P
authors.lastname: Ongolo-Zogo
authors.forename: G
authors.initials: G
authors.lastname: Louis-Tisserand
authors.forename: N
authors.initials: N
authors.lastname: Streichenberger
authors.forename: M
authors.initials: M
authors.lastname: Hermier
authors.forename: A
authors.initials: A
authors.lastname: Jouvet
authors.forename: C
authors.initials: C
authors.lastname: Hlaihel
authors.forename: E
authors.initials: E
authors.lastname: Jouanneau
authors.forename: G
authors.initials: G
authors.lastname: Salles
authors.forename: J C
authors.initials: JC
authors.lastname: Froment
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000473:pathology* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000502:physiology; D017352:Echo-Planar Imaging; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000473:pathology* / Q000503:physiopathology; D018810:Magnetic Resonance Angiography; D008297:Male; D008875:Middle Aged